Jefferies is making some adjustments to its Hologic HOLX estimates.
“We are increasing our F11 revenue estimate to $1,769M, from $1,750M, as well as our F11 pro-forma EPS estimate to $1.23, from $1.22. F11 consensus revenue and EPS currently stands at $1,755M and $1.23,” Jefferies writes.
“In addition, we are raising our F12 revenue and pro-forma EPS estimates to $1,941M and $1.45, from $1,875M and $1.40, respectively. F12 consensus revenue and EPS resides at $1,854.9M and $1.35, respectively.
“We believe that our estimates bake in significant conservatism as ASPs could be as high as $450K per system and the adoption ramp could be much higher than the assumptions in our model.”
Hologic closed Friday at $20.18.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in